Journal profile · MEDICINE, GENERAL & INTERNAL
BMJ Evidence-Based Medicine
ISSN 2515-446X · eISSN 2515-4478 · BMJ PUBLISHING GROUP · ENGLAND · Bi-monthly · Founded 2018
BMJ Evidence-Based Medicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 10.47; hybrid open access; APC charged, amount not published; review about 105 days (submission to first decision, publisher); 84 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
BMJ Evidence-Based Medicine is published by BMJ PUBLISHING GROUP and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Meta-analysis and systematic reviews, Health Sciences Research and Education and Health Systems, Economic Evaluations, Quality of Life, together about 31% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Publishes original research, insights and opinions on evidence-based research. Focuses on the tools, methods, and concepts that are central to practising evidence-based medicine.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, GENERAL & INTERNAL
Editor-in-chief Juan VAPublisher website
Editorial board by country: 1 in mainland China (about 6%); most named United Kingdom 4, Chile 3, India 2, Canada 2, South Africa 2 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Meta-analysis and systematic reviewsDecision Sciences15.4%
- Health Sciences Research and EducationHealth Professions8.2%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance7.5%
- Blood Pressure and Hypertension StudiesMedicine4.7%
- Clinical practice guidelines implementationMedicine4.5%
- Venous Thromboembolism Diagnosis and ManagementMedicine4.3%
- Asthma and respiratory diseasesMedicine4.2%
- Atrial Fibrillation Management and OutcomesMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, General & Internal | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Medicine, General & Internal | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.47LetPub ·
- Impact factor (publisher)
- 10.8Publisher website ·
- CiteScore 2026-06
- 10.8LetPub ·
- CiteScore (publisher)
- 10.8Publisher website ·
- SJR 2026-06
- 2.25LetPub ·
- SNIP 2026-06
- 2.34LetPub ·
- h-index
- 71OpenAlex ·
- i10-index
- 529OpenAlex ·
- 2-year mean citedness
- 6.51OpenAlex ·
- Self-citation rate
- 4.6%LetPub ·
- Share of gold OA articles
- 49.57%LetPub ·
Volume
- Articles per year
- 47LetPub ·
Articles by year OpenAlex count · 4,595 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 18 | 12 |
| 2025 | 84 | 47 | 450 |
| 2024 | 80 | 49 | 839 |
| 2023 | 80 | 44 | 1,398 |
| 2022 | 58 | 32 | 1,649 |
| 2021 | 68 | 25 | 1,413 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Submission to first decision
- 105 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted9
- analysisAnalysisLength not stated
- correspondenceCorrespondenceLength not stated
- editorialEditorialLength not stated
- educationEducationLength not stated
- letterLetterLength not stated
- opinionOpinionLength not stated
- original research (including evidence synthesis content)Original research (including evidence synthesis content)Length not stated
- patient voicesPatient voicesLength not stated
- research methods and reportingResearch methods and reportingLength not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMJ PUBLISHING GROUP
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bi-monthly
- Founded
- 2018
- ISSN
- 2515-446X
- Electronic ISSN
- 2515-4478
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about BMJ Evidence-Based Medicine
What CAS zone is BMJ Evidence-Based Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, BMJ Evidence-Based Medicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of BMJ Evidence-Based Medicine?
The latest impact factor listed by LetPub is 10.47; CiteScore 10.8, h-index 71.
How long does peer review take at BMJ Evidence-Based Medicine?
The publisher reports about 105 days (submission to first decision); first decisions include desk rejections. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of BMJ Evidence-Based Medicine based?
Of the 17 board members whose country the journal's board page names, 1 (about 6%) are in mainland China; the countries named most often are United Kingdom (4), Chile (3) and India (2). Counted from the institutions listed on the board page; for reference only.
Which databases index BMJ Evidence-Based Medicine?
According to LetPub and DOAJ records, BMJ Evidence-Based Medicine is indexed in SCIE and Scopus.
Is BMJ Evidence-Based Medicine open access, and what is the APC?
BMJ Evidence-Based Medicine is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .